The Phoenix Business Journal reports that Arizona startups raised $531.6 million across 44 deals in the second quarter of 2025, marking an increase from $344.7 million across 40 deals in the prior year quarter.
Three bio and life science companies were featured among the major deals:
- $100 million in an unspecified series round by Scottsdale-based women’s health tech company Naari.ai;
- $53.3 million in a series D round by Tempe-based GT Medical Technologies;
- $34 million series B round for EvolvedMD; and
- $13.5 million in a series A round by Scottsdale-based CND Life Sciences.
The growth of bioscience startups, including the raising of capital, helps to fulfill the goals of Arizona’s Bioscience Roadmap. The new Roadmap will be launched in September 2025.